Literature DB >> 31483560

Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects.

Federica Tonolo1, Michèle Salmain2, Valeria Scalcon1, Siden Top2, Pascal Pigeon2,3, Alessandra Folda1, Benoit Caron4, Michael J McGlinchey5, Robert-Alain Toillon6, Alberto Bindoli7, Gérard Jaouen2,3, Anne Vessières2, Maria Pia Rigobello1.   

Abstract

The ferrocenyl diphenol complexes 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (1) and 1,2-bis(4'-hydroxyphenyl)-1-ferrocenyl-but-1-ene [(Z)-2], which differ by the relative position of the two phenolic substituents, display dramatically different antiproliferative activities on cancer cells (1 is far more cytotoxic than 2). In this study, our goal was to discover the origin of this difference by comparing their reactivity and biological behaviour. In terms of common behaviour, we found that 1 and 2 are both efficient inhibitors of thioredoxin reductase (TrxR) in vitro after oxidation by a horseradish peroxidase/H2 O2 system. However, as 1 is only a moderate inhibitor of TrxR in MDA-MB-231 cells, TrxR is probably not the major target responsible for the cytotoxicity of 1. In terms of differences, we noted that 1 induced a significant redox imbalance characterised by lipid peroxidation and thiol oxidation, and a moderate decrease of the mitochondrial membrane potential in breast cancer cells, whereas 2 has almost no effect. These results underline the importance of the trans configuration in the ferrocenyl-double bond-phenol motif, which is present in 1 but is cis in (Z)-2.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bioorganometallic chemistry; cancer; iron; lipid peroxidation; thioredoxin reductase

Mesh:

Substances:

Year:  2019        PMID: 31483560     DOI: 10.1002/cmdc.201900430

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Succinimido-Ferrocidiphenol Complexed with Cyclodextrins Inhibits Glioblastoma Tumor Growth In Vitro and In Vivo without Noticeable Adverse Toxicity.

Authors:  Feten Najlaoui; Benoit Busser; Germain Sotoing Taïwe; Pascal Pigeon; Nathalie Sturm; Diane Giovannini; Naziha Marrakchi; Ali Rhouma; Gérard Jaouen; Stéphane Gibaud; Michel De Waard
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

2.  α-Hydroxylactams as Efficient Entries to Diversely Functionalized Ferrociphenols: Synthesis and Antiproliferative Activity Studies.

Authors:  Pascal Pigeon; Marie Gaschard; Mohamed Othman; Michèle Salmain; Gérard Jaouen
Journal:  Molecules       Date:  2022-07-16       Impact factor: 4.927

Review 3.  Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.

Authors:  Pierre Idlas; Elise Lepeltier; Gérard Jaouen; Catherine Passirani
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.